Research Progress on Anti-tumor Activity and Functionary Mechanism of Retinoic Acid

doi:10.13701/j.cnki.kqyxyj.2018.04.005

Abstract

Abstract: In normal tissues, retinoic acid is involved in the regulation of differentiation of various tissue stem cells and plays an important role in human development. Moreover, it has been proved that retinoic acid can inhibit tumor growth and induce differentiation of tumor stem cells. The purpose of this review is to present the literature on the antitumor activity of retinoic acid and its mechanisms, which provides the basis for future research.

Key words: Retinoic acid, Functionary mechanism, Cancer

SUN Bin, SUN Hong-chen. Research Progress on Anti-tumor Activity and Functionary Mechanism of Retinoic Acid[J]. Journal of Oral Science Research, 2018, 34(4): 356-358.

References

[1] Marlétaz F, Holland LZ, Laudet V, et al. Retinoic acid signaling and the evolution of chordates [J]. Int J Biol Sci,2006,2(2)∶38-47
[2] Duester G. Retinoic acid synthesis and signaling during early organogenesis [J]. Cell,2008,134(6)∶921-931
[3] Hugues de T, Christine C, MIchel L, et al. The t (15; 17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor or gene to a novel transcribed locus [J]. Nature, 1990, 347 (6293)∶558-561
[4] Xing M, Haugen BR, Schlumberger M. Progress in molecular-based management of differentiated thyroid cancer [J]. Lancet,2013,381 (9871)∶1058-1069
[5] Haugen BR, Larson LL, Pugazhenthi U, et al. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids [J]. J Clin Endocrinol Metab,2004,89(1)∶272-280
[6] Arrieta O, Gonzalez-De la Rosa CH, Rechaga-Ocampo E, et al. Randomized phase Ⅱ trial of all-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer [J]. J Clin Oncol,2010,28(21)∶3463-3471
[7] Bhaskar C, Thapa P, Karki R, et al. Retinoic acid signaling pathways in development and diseases [J]. Bioorg Med Chem,2014,22(2)∶673-683
[8] Masi AD, Leboffe L, Marinis ED, et al. Retinoic acid receptors:From molecular mechanisms to cancer therapy [J]. Mol Aspects Med,2015,41∶1-115
[9] Chambon P. A decade of molecular biology of retinoic acid receptors [J]. FASEB J,1996,10(9)∶940-954
[10] Bourguet W, Ruff M, Chambon P, et al. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha [J].Nature,1995,375 (6530)∶377-382
[11] Renaud JP, Rochel N, Ruff M, et al. Crystal structure of the RARgamma ligand binding domain bound to all-trans retinoic acid [J]. Nature,1995,378 (6558)∶681-689
[12] Hihi AK, Michalik L, Wahli W. PPARs:transcriptional effectors of fatty acids and their derivatives [J]. Cell Mol Life Sci,2002,59(5)∶790-798
[13] Chandra V, Huang YP, Hamuro S, et al. Structure of the intact PPARgamma-RXR- nuclear receptor complex on DNA [J]. Nature, 2008, 456(7220)∶350-356
[14] Al Tanoury Z, Piskunov A, Rochette-Egly C. Vitamin A and retinoid signaling: genomic and nongenomic effects [J]. J Lipid Res,2013,54(7)∶1761-1775
[15] Berry DC, Noy N. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor [J]. Mol Cell Biol,2009,29(12)∶3286-3296
[16] Moutier E, Ye T, Choukrallah MA, et al. Retinoic acid receptors recognise the mouse genome through binding elements with diverse spacing and topoloy [J]. J Biol Chem, 2012, 287(31)∶26328-26341
[17] Gudas LJ, Wagner JA. Retinoids regulate stem cell differentiation [J]. J Cell Physiol,2011,226(2)∶322-330
[18] Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors [J]. Genes Dev,2000,14(2)∶121-141
[19] Rosenfeld MG, Lunyak VV, Glass CK. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response [J]. Genes Dev,2006,20(11)∶1405-1428
[20] Epping MT, Wang L, Edel MJ, et al. The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling [J]. Cell,2005,122(6)∶835-847
[21] Giannì M, Bauer A, Garattini E, et al. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-indced RAR degradation and transactivation [J]. EMBO J,2002,21(14)∶3760-3769
[22] Alsayed Y, Uddin S, Mahmud N, et al. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid [J]. J Biol Chem,2001,276(6)∶4012-4019
[23] Piskunov A, Rochette-Egly C. A retinoic acid receptor RARalpha pool present in membrane lipid rafts forms complexes with G protein alphaQ to activate p38MAPK [J]. Oncogene, 2012, 31∶3333-3345
[24] Rochette-Egly C. Retinoic acid signaling and mouse embryonic stem cell differentiation: Cross talk between genomic and non-genomic effects of RA [J]. Biochim. Biophys Acta,2015,1851(1)∶66-75
[25] Gehani SS, Agrawal-Singh S, Dietrich N, et al. Polycomb group protein displacement and gene activation through MSK-dependent H3K27me3S28 phosphorylation [J]. Mol Cell,2010,39(6)∶886-900
[26] Sun R, Liu Y, Li SY, et al. Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells [J]. Biomaterials,2015,37∶405-414
[27] Sanchez AM, Shortrede JE, Vargas-Roig LM, et al. Retinoic acid induces nuclear FAK translocation and reduces breast cancer cell adhesion through Moesin, FAK, and Paxillin [J]. Mol Cell Endocrinol,2016,430∶1-11
[28] Chen XY, Yang M, Hao WJ, et al. Differentiation-inducing and anti-proliferative activities of isoliquiritigenin and all-trans-retinoic acid on B16F0 melanoma cells: Mechanisms profiling by RNA-seq [J]. Gene,2016,592(1)∶86-98